Counterfeit drugs pose great danger to patients for it could also worsen the conditions of the patients or even lead to fatal results.
The Food and Drug Administration issued on Monday, June 3, 2024 an advisory advising the public against the purchase and use of some drugs products. Consumers were also reminded to purchase drug products only from FDA-licensed establishments. “We also laud FDA’s action in calling the attention of healthcare professionals, drug outlets and establishments, including the local government units and law enforcement agencies, to ensure full compliance to Republic Act No. 9711, or the Food and Drug Administration Act of 2009, and Republic Act No. 8203, or the Special Law on Counterfeit Drugs.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: